Top 45 Life Science Angel Investors in United Kingdom (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Jonathan Milner
Angel
|
9 | United Kingdom, United States, Spain | Seed, Series A, Series B | Biotechnology, Health Care, Medical | $537k–$56M |
|
Nadav Rosenberg
Angel
|
4 | United Kingdom, France, Israel | Seed, Pre-Seed, Series A | Biotechnology, Artificial Intelligence, Software | $850k–$19M |
|
Jeff Dean
Angel
|
3 | United States, United Kingdom, Japan | Seed, Series A, Pre-Seed | Artificial Intelligence, Information Technology, Software | $450k–$53M |
|
Stefano Bernardi
Angel
|
3 | Italy, United Kingdom, France | Seed, Pre-Seed | Software, Biotechnology, Artificial Intelligence | $100k–$45M |
|
Aidan Gomez
Angel
|
2 | United States, United Kingdom, Canada | Seed, Pre-Seed, Series A | Artificial Intelligence, Software, Information Technology | $1.8M–$12M |
|
Mark Evans
Angel
|
2 | United Kingdom, United States, The Netherlands | Series A, Seed, Series C | Software, E-Commerce, Health Care | $1.4M–$24M |
|
Robert Kopple
Angel
|
2 | United States, United Kingdom | Convertible Note | FinTech, Finance, Life Science | |
|
Jude Gomila
Angel
|
2 | United States, United Kingdom, Canada | Seed, Pre-Seed, Angel | Software, Biotechnology, Information Technology | $190k–$4.7M |
|
Ian Hogarth
Angel
|
2 | United Kingdom, United States, Germany | Seed, Series A, Pre-Seed | Software, E-Commerce, Artificial Intelligence | $668k–$28M |
|
Mati Staniszewski
Angel
|
2 | United States, United Kingdom, Poland | Seed, Pre-Seed, Series A | Artificial Intelligence, Software, SaaS | $2M–$40M |
|
Ed Parkinson
Angel
|
2 | United Kingdom | Seed | Software, Health Care, Life Science | $1.8M–$3.3M |
|
Damien Lane
Angel
|
2 | United Kingdom, United States, Ireland | Seed, Pre-Seed, Series A | SaaS, Software, Health Care | $459k–$16M |
|
Darrin Disley
Angel
|
2 | United Kingdom | Seed, Series A | Biotechnology, Health Care, Big Data | $458k–$3.7M |
|
Bradley Horowitz
Angel
|
2 | United States, United Kingdom, Germany | Seed, Series A, Series B | Software, Information Technology, Artificial Intelligence | $150k–$120M |
|
Jim Warwick
Angel
|
1 | United Kingdom | Seed | Life Science, Biotechnology | |
|
Simon Galbraith
Angel
|
1 | Croatia, United Kingdom | Pre-Seed | Software, Health Care, Life Science | |
|
Nadav Ben-Chanoch
Angel
|
1 | United States, United Kingdom, France | Seed, Pre-Seed | Software, Information Technology, Health Care | $125k–$5.5M |
|
Mark Gillespie
Angel
|
1 | United States, United Kingdom, India | Seed, Series B | Music, Video, Internet | $2.7M–$13M |
|
Tim Davis
Angel
|
1 | United States, United Kingdom, Germany | Series A, Series B, Seed | Health Care, Biotechnology, Medical | |
|
Keith Willey
Angel
|
1 | United Kingdom, Spain, Portugal | Seed, Angel, Pre-Seed | Software, Gaming, Real Estate | $446k–$6.5M |
|
Jon Oringer
Angel
|
1 | United States, United Kingdom, France | Seed, Pre-Seed, Series A | Software, Information Technology, E-Commerce | $100k–$31M |
|
Nicholas Edwards
Angel
|
1 | United Kingdom | Seed | Medical, Health Care, Life Science | |
|
Michail Eleftheriou
Angel
|
1 | United Kingdom | Seed | Software, Life Science, Biotechnology | $150k–$900k |
|
Huw Bishop
Angel
|
1 | United Kingdom | Angel | EdTech, Training, E-Learning | |
|
Vishal Gulati
Angel
|
1 | United Kingdom, Hungary | Seed, Series A, Series B | Biotechnology, Biopharma, Life Science | $2.1M–$30M |
|
Fiona Pathiraja
Angel
|
1 | United Kingdom, Germany, Armenia | Pre-Seed, Seed, Series A | Health Care, Software, Wellness | $840k–$13M |
|
Johnathan Matlock
Angel
|
1 | United Kingdom | Seed, Pre-Seed | Medical, Biotechnology, Health Care | $1M–$6.1M |
|
Duncan Grierson
Angel
|
1 | United Kingdom | Seed, Series A | Water, Medical, CleanTech | |
|
Michelle Tempest
Angel
|
1 | United Kingdom | Seed, Series A | Health Care, Cannabis, Life Science | |
|
Edward Lando
Angel
|
1 | United States, France, United Kingdom | Seed, Pre-Seed | Software, Health Care, Information Technology | $125k–$6.6M |
|
Andrew Fisher
Angel
|
1 | United Kingdom | Series A | Medical, Life Science, Biotechnology | |
|
Matt Clifford
Angel
|
1 | United Kingdom, United States, India | Seed, Pre-Seed | Software, FinTech, Artificial Intelligence | $55k–$7M |
|
Will Brooks
Angel
|
1 | United Kingdom, United States | Seed, Series A | FinTech, Financial Services, Software | $524k–$30M |
|
Naheed Kurji
Angel
|
1 | United Kingdom | Seed | Life Science, Biotechnology | |
|
Jan Hruska
Angel
|
1 | United Kingdom | Seed | Medical, Health Care, Life Science | |
|
Rick Bernstein
Angel
|
1 | United Kingdom, The Netherlands | Seed, Pre-Seed | Biotechnology, AgTech, Farming | |
|
David Evans
Angel
|
1 | Israel, United Kingdom | Series A, Series D, Series E | Rental, Medical, Software | |
|
John Anthony Knight
Angel
|
1 | United Kingdom | Seed | Software, Life Science, Biotechnology | |
|
Maximilien Levesque
Angel
|
1 | United Kingdom | Seed | Life Science, Biotechnology | |
|
Sharaf Yamani
Angel
|
1 | India, United Kingdom | Seed | Biotechnology, Software, Life Science | $900k–$1.4M |
|
Amar Shah
Angel
|
1 | United Kingdom, Poland, Germany | Pre-Seed, Seed, Angel | Artificial Intelligence, Software, Health Care | $642k–$15M |
|
Irina Elena Haivas
Angel
|
1 | United Kingdom, Estonia, Germany | Series A, Series B, Seed | Health Care, Biotechnology, Artificial Intelligence | $11M–$56M |
|
Sami Mikati
Angel
|
1 | India, United Kingdom | Seed | Biotechnology, Software, Life Science | $900k–$1.4M |
|
Patrick Pichette
Angel
|
1 | United Kingdom, Germany, United States | Seed, Series A, Series B | Artificial Intelligence, Software, Machine Learning | $750k–$95M |
|
David Lucas
Angel
|
1 | United Kingdom | Seed | Software, Life Science, Biotechnology | |
| Access all 58 angel investors in United Kingdom Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Spain
Investor stats
- Total investments: 61
- Round size: Seed $537k–$16M; Series A $4.1M–$50M; Series B $1.6M–$56M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Nuclera — Nuclera makes biology accessible through desktop enzymatic protein and gene synthesis. Nuclera has since grown to fifty-seven employees across two continents as the Company delivers on its founders’ vision to make biology accessible to everyone through desktop bioprinting. With desktop bioprinting, researchers and scientists will be empowered totake control of biology through streamlined access to a next-day supply of proteins and genes.
- 52 North Health — At 52 North we are developing fully-integrated clinical, AI and medical-device based systems.
- Constructive Bio — We place non-canonical amino acids at precise positions in proteins and peptides to create therapeutics with new properties, then manufacture them through fermentation.
Nadav leads Taboola’s expansion and operations in Europe and Australia.Prior to joining Taboola, Nadav was a member of the founding team of Groupon UK & IR, taking part in building and managing Groupon’s business in the UK.Before joining Groupon, Nadav worked as a strategy consultant with McKinsey & Company in London.Nadav isbased in London and holds an MBA from INSEAD, France.
Show more...Investment focus
- Industry: Biotechnology, Artificial Intelligence, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, France, Israel
Investor stats
- Total investments: 15
- Round size: Seed $850k–$3.1M; Pre-Seed $2M–$2M; Series A $18M–$19M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- Qantev — Qantev is the leading AI claims platform for health & life insurance, enabling insurers to automate claims operations, reduce leakage, improve loss ratios, enhance data quality, and elevate customer experience.
- thymia — We use video games based on Neuropsychology alongside analyses of video and speech to make mental health assessments smart, starting with depression.Our online platform empowers clinicians so they can assess depression faster, more accurately and objectively. Our multi-modal depression recognition and tracking system allows us to find the righttreatment in weeks instead of years and we make the entire process enjoyable for the patient.
- Exogene — Exogene is a biotechnology company accelerating the discovery of T-cell-receptor(TCR)-based cancer immunotherapies for solid tumours by combining deep learning and high-throughput TCR-antigen screening. Exogene is building a computational platform to quickly and inexpensively identify new tumour targets shared across cancer patients, as well assafe and effective TCRs against these tumour targets for therapeutic application. Their mission is to develop better TCR-based immunotherapies, faster and at a fraction of the cost.
Jeff Dean is the Chief Scientist of Google DeepMind and Google Research. He joined Google in 1999 and has played a pivotal role in shaping the company’s technical foundations. He currently focuses on advancing AI and deep learning research across Google’s research teams.He co-founded and led the Google Brain team, helping drive innovations indeep learning for speech recognition, computer vision, natural language understanding, and a wide range of predictive applications. Over the years, he has co-designed and implemented several generations of Google's core systems, including its web search infrastructure, crawling and indexing pipelines, and advertising technologies such as AdSense for Content.He is also a key contributor to Google's distributed computing infrastructure, having co-designed and implemented systems like MapReduce, BigTable, Spanner, Protocol Buffers, LevelDB, and TensorFlow—one of the most widely used open-source machine learning platforms.Jeff Dean earned his Ph.D. in Computer Science from the University of Washington in 1996. He is a Fellow of the ACM, a member of the U.S. National Academy of Engineering and the American Academy of Arts and Sciences, and a recipient of the ACM-Infosys Foundation Award in the Computing Sciences and the Mark Weiser Award.
Show more...Investment focus
- Industry: Artificial Intelligence, Information Technology, Software
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, United Kingdom, Japan
Investor stats
- Total investments: 87
- Round size: Seed $2.3M–$35M; Pre-Seed $450k–$3M; Series A $6.1M–$53M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- Altara — Altara is a San Francisco–based startup building a scientific-intelligence AI platform that analyzes complex physical-science and engineering data (batteries, chips, materials, etc.) to speed up R&D and failure analysis.
- Periodic Labs — Periodic Labs develops artificial intelligence systems that simulate and predict the properties of materials using machine learning. The company applies computational models to support the discovery and design of materials used in sectors such as energy, electronics, and infrastructure. It builds tools that aim to reduce the time and costassociated with traditional research and development processes. Periodic Labs uses AI to analyze large-scale scientific data and collaborates with academic and industry partners to support material science research.
- depthfirst — An AI-native security platform that understands your code, business logic, and infrastructure to find more vulnerabilities, slash false positives, and give developers actionable fixes in their workflow.
Stefano Bernardi is the Investment Director, Climate at Fondazione ENEA Tech.
Show more...Investment focus
- Industry: Software, Biotechnology, Artificial Intelligence
- Stage:Seed, Pre-Seed
- Geography: Italy, United Kingdom, France
Investor stats
- Total investments: 17
- Round size: Seed $100k–$45M; Pre-Seed $1.4M–$2.2M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- iubenda — Make your sites & apps legally compliant across multiple languages and legislations (including the GDPR) with our lawyer-crafted, self-updating solutions.
- Eden Bio — Eden Bio is a biotech using machine learning to guide the genetic engineering of microorganism strain optimisation, improving protein yield.
- Golden — Golden is a developer of a self-constructing knowledge database used to accelerate discovery and education. The company uses and leverages human effort by using machine intelligence to make the process of gathering and communicating knowledge simpler.It combines a powerful search across several entities with fine-grain alerts to stay on top ofchanges, and semi-automatic research assistance for gaps in knowledge that enable people in organizations to stay current, understand and leverage the latest trends in their industry.
Aidan Gomez is based out of Toronto, Ontario and is the co-founder & CEO at Cohere. Aidan Gomez attended the University of Oxford.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 17
- Round size: Seed $2.4M–$12M; Pre-Seed $1.8M–$3.5M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Extropic AI — The next era of computing isn't dead. It's alive. More coming soon.
- Latent Labs — Latent Labs is making biology programmable to transform health and sustainability for the benefit of all.We are a frontier AI lab building foundational models that capture the fundamentals of biology. We empower partners with breakthrough generative AI to gain unprecedented control over molecular biology, creating new antibodies, optimizingexisting enzymes, and advancing genetic engineering.Contact us to work with us today.
- Helical — The full power of DNA & (m)RNA Bio Foundation Models in one open-core platform. Accelerate Drug Discovery with AI.
Mark is currently a Founding Partner and LP and Investment Committee member at Kindred Capital, a European Seed-Stage Venture fund, based in London. He was a General Partner at Balderton Capital/ Benchmark Europe from 2002 through 2015, and an EIR at Benchmark Capital in 1999/2000.He spent the prior 15 years @ Goldman Sachs, where hewas a General Partner and Management Committee member. He studied Economics at both University of Oxford and Queen's University in Canada.
Show more...Investment focus
- Industry: Software, E-Commerce, Health Care
- Stage:Series A, Seed, Series C
- Geography: United Kingdom, United States, The Netherlands
Investor stats
- Total investments: 35
- Round size: Seed $1.4M–$8M; Series A $3.2M–$24M; Series C $8M–$24M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- 8fit — Get personalized workouts, custom meal plans, and nutrition guidance, right in the palm of your hand. Prioritize progress over perfection with the 8fit app!
- Ufonia — Dora is a clinical AI agent that calls and supports your cataract patients, empowering your ophthalmology practice to scale without compromise on care.
- Arctoris — Arctoris is a platform company headquartered in Oxford, with its US operations based in Boston and its APAC operations based in Singapore. Arctoris developed and operates a unique drug discovery platform powered by advanced robotics and data science combined with an experienced team of biotech & pharma veterans. Arctoris actively pursuesseveral drug discovery programs in oncology and neuro, while also providing access to its platform to select biotech and pharma partners. Arctoris' approach of data-driven drug discovery leads to higher chance of success, and an accelerated progression of programs towards the clinic.
Robert Kopple
Show more...Investment focus
- Industry: FinTech, Finance, Life Science
- Stage:Convertible Note
- Geography: United States, United Kingdom
Investor stats
- Total investments: 3
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Tradier — Tradier is a financial services cloud provider that offers a groundbreaking solution to serve platform providers, developers and investors. The Tradier solution features an innovative set of fully hosted APIs, modules, and "out of the box" tools that are leveraged by a growing list of providers.
- ILC Therapeutics — ILC Therapeutics Ltd is an early-stage biotechnology company focused on modulating the Innate Immune System through the development of novel peptide therapeutics for the treatment of Covid-19, Cancer, Atopic Dermatitis, and Psoriasis.
Jude Gomila is currently CEO and Founder of the startup Golden.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Pre-Seed, Angel
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 55
- Round size: Seed $1.4M–$4.7M; Angel $190k–$1.3M; Pre-Seed $1M–$2.8M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- HockeyStack — HockeyStack enables marketing teams to drive pipeline efficiently and sales teams to close deals faster with modern attribution, holistic buyer journeys, and account insights.
- Farmako — Install Farmako app, get a free health ID and get all your medical records safe and secure in one place!
- Athens Research — Open-Source Roam Research. A private, extensible, and community-driven knowledge graph.
Ian Hogarth is based out of London, England, and is the Chairman of Phasecraft. Ian previously worked at Songkick as a Chairman. Ian Hogarth attended the University of Cambridge.
Show more...Investment focus
- Industry: Software, E-Commerce, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 55
- Round size: Seed $1.5M–$8.8M; Pre-Seed $668k–$7.7M; Series A $11M–$28M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Blloc — The ultimate smartphone experience. Boost your productivity. Focus on what matters.
- Cordless — Bridging the gap between voice and text
- Heygo — Explore places to visit within the UK and around the world on Rest Less. Get inspired and plan trips to holiday destinations with us.
Mati Staniszewski is the Co-Founder of ElevenLabs.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, SaaS
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, Poland
Investor stats
- Total investments: 12
- Round size: Seed $5M–$10M; Pre-Seed $2M–$5M; Series A $16M–$40M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- CodeWords —
- VitVio — VitVio is a platform built around AI and computer vision with the goal of improving efficiency and quality of care in operating rooms.
- Elastics — Elastics is an AI-native operating system for prediction markets and beyond. Powered by auditable AI agents, it allows traders to build and automate trading workflows in plain language, from signal generation to live execution.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Ed Parkinson
Show more...Investment focus
- Industry: Software, Health Care, Life Science
- Stage:Seed
- Geography: United Kingdom
Investor stats
- Total investments: 2
- Round size: Seed $1.8M–$3.3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Antiverse — Designing biologics for 100 challenging targets
Damien Lane has spent the last 20 years investing in private companies, both in Private Equity where he was a partner with Electra Partners, then at Octopus Ventures where he was a senior member of the investment team. Having made a number of angel investments, Damien co-founded Episode 1 with Simon and Adrian in 2012. While at Episode 1,Damien has led investments in Carwow, Scurri, Touch Surgery, Attest and Zipcube and loves working with early stage teams of entrepreneurs; helping them develop their early stage startup into a fast growth enterprises capable of raising more funding from later stage investors. When he is not trying to help businesses to implement an optimal approach to growth, Damien can mostly be found running around Hampstead Heath or the Coastal paths of Great Britain. Having trained obsessively to run a 2:52 Marathon in 2015, he is now trying to dip below 2:50, in the spirit of continuous improvement. Damien has an MBA from Cambridge University and a Masters degree in PE from Oxford University.
Show more...Investment focus
- Industry: SaaS, Software, Health Care
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 38
- Round size: Seed $459k–$3.1M; Pre-Seed $605k–$1M; Series A $3.2M–$16M
- Lead/follow: 37% lead, 63% follow
Portfolio highlights
- Calira — Calira (formerly Clustermarket). Give researchers an easy way to book equipment, improve equipment utilisation, and get structured lab usage data.
- Realla — Search the entire commercial property market for offices, serviced office space, retail, industrial for sale and to rent
- IVO — Platform to allow media owners to deepen advertiser engagement, increase profitability and commercialise ad solutions with ease.
Darrin Disley is the CEO, Director & Investor at Mogrify. He attended University of Cambridge.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Big Data
- Stage:Seed, Series A
- Geography: United Kingdom
Investor stats
- Total investments: 4
- Round size: Seed $458k–$3.7M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- bit.bio — Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell. Their mission is coding cells for health. To do so, we apply the principles of computation to biology. Bit.bio's current focus is to develop a scalable technology platform capable of producing consistent batches of every human cell. Thishas the potential to unlock a new generation of medicine: it will enable research and drug discovery to move on from inappropriate models and work with the cells that actually are affected by the human disease. A scalable platform of consistent cells will also be the basis for a new generation of cell and tissue therapies. To achieve our goals, we have assembled a team of pioneers in stem cells, cellular reprogramming, mathematical modeling, and cell therapy. Collaboration is at the heart of bit.bio. We are empirical, highly ambitious, and driven by a common purpose.
- Mogrify — Mogrify is pioneering a new class of in vivo reprogramming therapy and transforming the development of ex vivo cell therapy.
- Desktop Genetics — Desktop Genetics is an international biotechnology company established in 2012 to help researchers discover and treat the root genetic causes of human disease. Today, Desktop Genetics is a recognised leader in genome editing technology, staffed by dedicated team of genome editing experts, bioinformaticians and data scientists, driven by thereal-world impact of CRISPR technology.They have invested four years developing their core technology, DESKGEN AI, trained on the largest database of genome editing data in the world. DESKGEN AI powers their flagship DESKGEN CRISPR Library product range, which enables the work of their pharma, biotech and academic customers working in drug discovery and functional genomics. Desktop Genetics' tools and technologies are used by over 1800 organisations all over the world, and their projects contribute directly to several key partnerships to bring CRISPR into the clinic. The company has received awards from Fast Company, Kairos 50 and SxSW Interactive.
Bradley Horowitz is an Advisor and Vice President of Product Management at Google. Most recently he helped create Area 120, Google's incubator for internally-sourced innovation. He's led a large number of products, programs and initiatives at Google - including Google for Startups, Google Photos, Gmail, Google Voice, blogger, and GoogleNews.Before joining Google in February 2008, Horowitz was Yahoo's vice president of Advanced Development where he drove the acquisitions of Flickr and MyBlogLog, launched the Brickhouse incubator and developed new products like Yahoo! Pipes. Additionally, he was responsible for the company's initiative to open up its platform which included overseeing the Yahoo Developer Network (YDN).Previously, he was co-founder and CTO of Virage, where he oversaw the technical direction of the company from its founding through its IPO and eventual acquisition by Autonomy.Horowitz was a PhD candidate at the MIT Media Lab. While at the Media Lab, he worked on a number of topics related to computer vision, graphics and image processing, which resulted in a patented new technique for the recovery of structure, motion and camera parameters from video sequences.Horowitz holds an MS in Media Science from MIT and a BS in Computer Science from the University of Michigan.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 114
- Round size: Seed $150k–$18M; Series A $5.8M–$36M; Series B $19M–$120M
- Lead/follow: 1% lead, 99% follow
Portfolio highlights
- Key AI — Unlock new networking and career opportunities with Key, the leading AI-powered professional networking platform. Build and manage communities, host and join exclusive events, and create meaningful connections to supercharge your growth all in one place.
- OrgOrg — OrgOrg provides internal SaaS tools for organizational productivity suite for the companies
- Odyssey — Odyssey operates as an AI start-up, provides hollywood-grade visual AI.
Jim started work at Analysys Limited, a Cambridge-based telecommunications consultancy, heading up its IT, software and web development initiatives. Jim then joined Abcam as a Technical Director, and took over the operational management of the UK office as Managing Director in June 2004, working on both cost saving and efficiency improvementprojects. In 2009, Jim became Chief Operating Officer, with the responsibility for overseeing the operational strategy of the Group. Jim is a Director of Chesterton Community College, Chesterton Sports Centre Limited and Cambridge Nutraceuticals Limited. He has also taken up a non-executive position at Quartix Holdings Plc. Jim had over 15 years’ experience in developing and implementing IT systems and strategy before moving into a broader operational management role within Abcam.Here his skills have been particularly focused on developing a scalable operating model for Abcam which, supported by IT systems, has underpinned Abcam’s rapid growth over the past decade.
Show more...Investment focus
- Industry: Life Science, Biotechnology
- Stage:Seed
- Geography: United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Qkine — Growth Factors made for stem cells Animal-free We control every step of protein manufacture ensuring all our products are completely animal-free Total transparency Stringent purity and bioactivity testing data for all proteins - know what you are giving your cells Protein innovation Our R&D team
Simon is the joint founder and CEO of Redgate Software. Over the past 15 years, Simon has been part of Redgate’s growth from a 2 person firm operating out of a spare room to today’s 300 person outfit with hundreds of thousands of users. Although Simon’s responsibilities are primarily strategic, his background is technical with qualificationsincluding a PhD in physics from Cambridge University and former employment with Shell and ThornEMI.
Show more...Investment focus
- Industry: Software, Health Care, Life Science
- Stage:Pre-Seed
- Geography: Croatia, United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- BoobyBiome — BoobyBiome harnesses breast milk microbiome science to develop products to improve infant health
- SysKit — Syskit Point is your go-to platform for governing the entire M365 lifecycle. Reporting, auditing, and governance - simplified. Start your 21-day free trial.
Nadav Ben-Chanoch
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Pre-Seed
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 169
- Round size: Seed $329k–$5.5M; Pre-Seed $125k–$2.5M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Swaap — We we build & operate onchain trading systems.
- micro1 — We help companies hire and manage the best software engineers easily.
- Dotfile — Dotfile is the Compliance Orchestration Platform for Fintechs. Streamline KYC & KYB and scale AML/CFT due diligences over +200 countries.
Mark Gillespie, born in Solihull, August 30th 1981, is a prominent music industry executive and entrepreneur, currently serving as the CEO of Three Six Zero, a global entertainment management company. With a career spanning over two decades, Gillespie has been instrumental in managing and guiding the careers of high-profile artists, producers,and creatives, including internationally acclaimed stars like Calvin Harris, Frank Ocean and Kid Cudi. Beyond his role at Three Six Zero, he owns the record label, Three Six Zero Recordings, Three Six Zero Music Publishing, and an interest in UK film distribution company, True Brit Entertainment. He is also credited as an executive producer on the movies Vox Lux (starring Natalie Portman and Jude Law) The Brutalist (starring Adrien Brody, Joe Alwyn and Felicity Jones) and Marching Powder (starring Danny Dyer).In 2023 he purchased the legendary SARM Recording Studios in London.Additionally Mark is an active investor in the technology space and holds a portfolio of investments in businesses such as Openai, SpaceX, Doordash, Figma, Stripe, OpenSea Gemini and Lyft. As well as being an LP at Andreessen Horowitz.He serves on the entertainment board of the charity Children In Conflict. His forward thinking vision and innovative approach to talent management have positioned Three Six Zero as a leading entity in the industry, known for representing leading talent in their respective fields of music, film, television and sports.
Show more...Investment focus
- Industry: Music, Video, Internet
- Stage:Seed, Series B
- Geography: United States, United Kingdom, India
Investor stats
- Total investments: 20
- Round size: Seed $2.7M–$5M; Series B $6M–$13M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Bkstg — Bkstg was founded by tech and music entrepreneurs to reinvent the way artists and fans connect by creating a new form of direct relationship that’s never existed before.
- Hyperice — From massage guns to compression boots and contrast therapy. Hyperice creates professional-grade recovery tools trusted by elite athletes and everyday movers worldwide.
- Biosceptre — A Promise Beyond Cancer Envisioning the future of targeted therapeutics Biosceptre is driving innovation to bring new and progressive therapies to a wide range of cancer patients. Our focus is a multiple-targeted universal CAR T system with the potential to improve the lives of millions of patients across the world who are suffering from
Timothy T Davis, MD is Board Certified in Physical Medicine and Rehabilitation (Physiatry) and Pain Medicine. The founder of Source Healthcare, Source Surgery Center, Alpha Diagnostics and he is an expert in spine and musculoskeletal disorders as well as interventional pain management to treat neck, back and sports injuries. Dr. Davis hasperformed extensive clinical research using biological therapies such as stem cells and other biologics for spine and joint injuries. He has consulted and invested in SaaS, medical device, biologics, cannabis, and psychedelics sectors.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 10
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Bryn Pharma — Bryn Pharma is a pharmaceutical company that offers nasal-based epinephrine for anaphylaxis. Its bi-dose intranasal device is an alternative to epinephrine auto-injectors and is needle-free. It is easy to use and portable enabling patients to treat allergic reactions or anaphylactic reactions.
- Beckley Psytech — Our mission is to help people suffering from neurological and psychiatric conditions by developing our pipeline of psychedelic compounds.
- MycoMedica Life Sciences, PBC — Psychedelic Medicines
Keith is an associate professor of strategic and international management and entrepreneurship at London Business School as well as a senior lecturer at University College London. He also holds various non-executive directorships and advisory roles. His career has spanned academia, consulting, investing and hands-on operational roles withinindustry and the venture capital world.
Show more...Investment focus
- Industry: Software, Gaming, Real Estate
- Stage:Seed, Angel, Pre-Seed
- Geography: United Kingdom, Spain, Portugal
Investor stats
- Total investments: 9
- Round size: Seed $1.4M–$6.5M; Angel $446k–$1.3M; Pre-Seed $721k–$2.2M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Rise Art — Discover, own and collect contemporary art from exciting artists from around the world. Explore our online art gallery with artwork for sale that has been expertly vetted by our curators. Buy or rent art online with confidence with free art advisory.
- NumberEight — Empower your targeting and curation with NumberEight's smart, privacy-first data. Designed for publishers, ad platforms and agencies to drive performance across podcasting, mobile and CTV.
- Urban Roosters — Urban Roosters is the original rap streaming platform. The RAP unlike other types of music, has always had a competitive spirit. What they do in Urban Roosters is to bring this competitions to internet, letting our users compete with rappers all over the world, trespassing the physical as an entertainment platform for the rap lovers.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Jon Oringer is the founder and chairman of Shutterstock.
Show more...Investment focus
- Industry: Software, Information Technology, E-Commerce
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 133
- Round size: Seed $1.1M–$5.5M; Pre-Seed $100k–$3.3M; Series A $4M–$31M
- Lead/follow: 1% lead, 99% follow
Portfolio highlights
- SLUSHY — SLUSHY is a secure mobile web based platform for content creators to find, grow, & monetize their audiences. A creator first, tech-driven tool, designed with key discoverability features and audience insights. In a market where existing solutions (OnlyFans, Patreon) fall short of their creators' demands, SLUSHY provides an alternativesolution for professional content creators that prioritizes their monetization, support and management needs. SLUSHY incorporates a powerful legal framework, with robust compliance tools including simplified consent, ID verification, and content moderation. The new home of unrestricted content, SLUSHY is here.
- Unsloth AI — Unsloth is an open-source, no-code web UI for training, running and exporting open models in one unified local interface.
- OneImaging — OneImaging makes life-saving diagnostics affordable, accessible, and personal. We connect employers, health plans, and members to a trusted national network of imaging centers, delivering faster answers with transparent pricing and premium care across MRIs, CT scans, ultrasounds, mammograms, X-rays and more. We serve organizations looking to control medical spend and individuals who need reliable results without delays. Every scan booked through OneImaging is proof that healthcare can be simpler, cheaper, and kinder.
Nick serves as the Chairman of Prescient’s Board of Directors. He holds a degree in physiological sciences from The Queen’s College, University of Oxford, and completed his training in clinical medicine (BM, BCh) at Green College (now Green Templeton College), University of Oxford. Nick practiced in the areas of cardiology and general surgerybefore joining Andersen Consulting (now known as Accenture), eventually becoming the global leader of Accenture’s pharmaceutical R&D business during his 18-year tenure. In 2005, he founded Kinapse to provide consulting and outsourcing services to the pharmaceutical industry. Nick served as Kinapse’s Chairman until the company was sold to HgCapital in early 2016.
Show more...Investment focus
- Industry: Medical, Health Care, Life Science
- Stage:Seed
- Geography: United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.
Michail Eleftheriou
Show more...Investment focus
- Industry: Software, Life Science, Biotechnology
- Stage:Seed
- Geography: United Kingdom
Investor stats
- Total investments: 2
- Round size: Seed $150k–$900k
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Synthace — The Synthace Experiment Platform lets you design powerful experiments, run them in your lab, & gather automatically structured datasets. No code necessary.
- 2Go Mobile Now —
Huw Bishop is an individual investor.
Show more...Investment focus
- Industry: EdTech, Training, E-Learning
- Stage:Angel
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- clear_pixel VR — We build VR and AR training platforms and product demonstrations for education and enterprise.
Vishal Gulati: Vishal serves as a venture partner specialising in digital health at DFJ Esprit, Europe's leading Silicon Valley style venture capital firm with over $1b under management. Since 2012, Vishal has been Europe’s leading promoter of investment into the emerging digital health sector and chairman of Digital Health Forum, whichsupports the best in class digital health companies to grow into global enterprises. Vishal serves on several boards including Horizon Discovery Group PLC (Cambridge, UK), a gene editing company; Fluidics Analytics (Cambridge, UK), a next gen protein discovery engine, Frameshift a healthcare information flow platform (London, UK) and EcoEos (San Francisco, USA), a consumer genomics business. His previous investments include Napo Pharmaceuticals, Glenmark, Renovo and Phagenesis.
Show more...Investment focus
- Industry: Biotechnology, Biopharma, Life Science
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, Hungary
Investor stats
- Total investments: 8
- Round size: Seed $3.2M–$8M; Series A $2.1M–$12M; Series B $6.8M–$30M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Arctoris — Arctoris is a platform company headquartered in Oxford, with its US operations based in Boston and its APAC operations based in Singapore. Arctoris developed and operates a unique drug discovery platform powered by advanced robotics and data science combined with an experienced team of biotech & pharma veterans. Arctoris actively pursuesseveral drug discovery programs in oncology and neuro, while also providing access to its platform to select biotech and pharma partners. Arctoris' approach of data-driven drug discovery leads to higher chance of success, and an accelerated progression of programs towards the clinic.
- Verisian — Verisian accelerates drug time to market with the industry's first platform offering real study traceability (CDISC, SDTM, ADaM, TFLs)
- Turbine — Turbine is virtualizing biological experiments with AI to accelerate drug discovery and enhance clinical translatability.
Fiona is Managing Partner at Crista Galli Ventures, an early stage healthtech VC fund based in London and Copenhagen.
Show more...Investment focus
- Industry: Health Care, Software, Wellness
- Stage:Pre-Seed, Seed, Series A
- Geography: United Kingdom, Germany, Armenia
Investor stats
- Total investments: 15
- Round size: Seed $1.1M–$4.5M; Pre-Seed $840k–$2.5M; Series A $10M–$13M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Unfabled — Menstrual care and wellness products for your cycle. Organic period products in sustainable packaging. Curated brands for skincare, sleep, cravings, cramping, mood swings, and relaxation. For all your self-care needs, we have you covered.
- Bloom Money — Bloom Money is a savings club app designed to help growing communities in migrant communities and use technology to promote community, safety, and convenience.
- Everyman Health — Everyman Health ist Spezialist für Männergesundheit und bietet wissenschaftlich fundierte Lösungen für Männer aller Altersgruppen. In Zusammenarbeit mit unseren Partnern, bieten wir dir ein umfassendes Portfolio von digitalen, medikamentösen und nicht-medikamentösen Therapien für unterschiedliche Männerprobleme.Über unsere Plattform wirst du inwenigen Minuten mit einem Schweizer Facharzt verbunden und erhältst eine persönliche Diagnose und gegebenenfalls ein Rezept.Auf Wunsch wird deine persönliche Behandlung von einer lizenzierten Schweizer Apotheke diskret verpackt und dir kostenlos bis vor die Haustür geliefert.
Johnathan Matlock is Co-Founder Science Angel Syndicate.
Show more...Investment focus
- Industry: Medical, Biotechnology, Health Care
- Stage:Seed, Pre-Seed
- Geography: United Kingdom
Investor stats
- Total investments: 10
- Round size: Seed $1M–$6.1M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- OutSee — We are well-versed in a variety of genomics, AI and cohort analysis techniques. We are also bioinformatics generalists and work with just about any ...
- EnsiliTech — EnsiliTech is a biotechnology start-up developing ensilication, a platform technology, to remove the need for refrigeration when transporting and storing vaccines and biologicals
- Halo Therapeutics — Halo Therapeutics is based in England. Develops safe pan coronavirus antiviral drugs for Covid-19 that can be administered by patients.
Duncan Grierson
Show more...Investment focus
- Industry: Water, Medical, CleanTech
- Stage:Seed, Series A
- Geography: United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Puraffinity — Puraffinity develops targeted materials for water treatment, focused on forever chemicals called PFAS. Our strategic intent is to provide 1 billion people with PFAS safe water by 2030
- Moixa Technology — Moixa Technology develops the Maslow intelligent energy storage solution, enabling homes to store energy and benefit from revenue streams generated by trading energy through GridShare, an SaaS platform that aggregates energy from groups of Maslow energy storage systems. . The company develops smart DC technologies to power DC lighting, computing,electronics from grid-shifted storage or local PV from smart DC hubs, variable DC networks and sockets. The technology and IPR reduces grid peak by shifting DC device load and powering DC devices efficiently without inverters or AC/DC adaptors, together with providing smart control and energy management. The technology aims to address the 1 trillion kwh + lost annually in power conversion, and the significant growing DC demand in homes, offices from ICT, LED lighting and the rise in internet connected devices.
Michelle Tempest
Show more...Investment focus
- Industry: Health Care, Cannabis, Life Science
- Stage:Seed, Series A
- Geography: United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Daye — Daye has set out to build a new brand for female health products “designed with women in mind.” The startup’s first product is a newly developed tampon that uses CBD to help tackle period cramps (or dysmenorrhea) as an alternative to traditional painkillers (CBD is the extract derived from the flower of the industrial hemp plant, a legal relativeto marijuana).
- Medwise.ai — Medwise.ai is the Google for doctors.
Edward Lando is the founder of Pareto Holdings. He previously worked at Horizons School of Technology as a co-founder. Edward Lando attended the Wharton School.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Pre-Seed
- Geography: United States, France, United Kingdom
Investor stats
- Total investments: 314
- Round size: Seed $500k–$6.6M; Pre-Seed $125k–$3.3M
- Lead/follow: 1% lead, 99% follow
Portfolio highlights
- Swaive — Swaive operates a financial firm that invests in risk-free instruments. The organization allows you to park your money without risk.
- AstroForge — We mine asteroids to extract valuable minerals in space at a lower cost and smaller carbon footprint than the current terrestrial mining methods.
- Autoplay — Autoplay is an AI-powered platform that improves digital adoption by offering real-time, context-aware guidance. It learns from user interactions and software interfaces, adapting to help enterprises optimize usage, streamline workflows, and boost engagement across teams.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!As an Executive Vice President at Wesley Clover, Andrew currently manages a portfolio of ICT and Digital Media companies globally. In addition he also acts as a business prime for the Wesley Clover affiliate program.Andrew connects teams of new graduates with tier one Network Operator, Service Provider and Communications EquipmentManufactures globally. These partnerships provide invaluable customer insight and a route to market for each of the Affiliates. Through these partnerships, each party realizes time to revenue, time to market and engine for innovation advantage.Andrew serves on the Board of Directors for March Entertainment, Benbria and Teldio Corporations. He is also a member of the Advisory board for the Canadian Digital Media Network and the Canadian Department of Foreign Affairs and International Trade Information and Communications Technologies.Andrew is an honors graduate from the University of British Columbia, with an academic background in Computer Science, Engineering and Economics.
Show more...Investment focus
- Industry: Medical, Life Science, Biotechnology
- Stage:Series A
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- MIP Diagnostics — MIP Diagnostics develop and manufacture molecularly imprinted polymers (nanoMIPs) that act as synthetic alternatives to antibodies for IVD and other industries.
Matt co-founded EF after being a consultant at McKinsey & Co. Prior to EF Matt spent his time studying at MIT fuelled by an obsession with R, Python and unusual datasets. EF is the best place for Europe’s top technical individuals to meet and build world-changing startups in London.They select purely on the basis of technical talent, so youcan apply before you have a team or an idea. The intensive 6-month programme is designed to give you the best possible support in the first 200 days of your startup’s life.They have created over 40 startups now worth over $300 million. The startups are funded by some prestigious investors including Balderton Capital, Index Ventures, Octopus Investments and Y Combinator.
Show more...Investment focus
- Industry: Software, FinTech, Artificial Intelligence
- Stage:Seed, Pre-Seed
- Geography: United Kingdom, United States, India
Investor stats
- Total investments: 39
- Round size: Seed $764k–$7M; Pre-Seed $55k–$4.2M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Claimer — Claimer is a self-service application that gets credit claims done easily of money spent on research and development. Its platform empowers company owners and advisors to prepare their claims, without any specialist knowledge, no matter how big or small the claim. It also prepares and submits the amended tax return for free.Claimer was founded in2019 by Adam McCann and is headquartered in Croydon, United Kingdom.
- Bondaval — Bondaval insures receivables for the world's best credit teams, so they can extend more credit, win more business and get better financing terms.
- Koos — KOOS is a simple legal and technological solution for motivating and rewarding your community. Boost your growth by sharing success.
Will Brooks - Founder & Director @ Portfolio Ventures
Show more...Investment focus
- Industry: FinTech, Financial Services, Software
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 69
- Round size: Seed $524k–$3.1M; Series A $2.2M–$30M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Disputed — FinLegal is legaltech for the business of disputes. Our solutions allow you to fund and insure your litigation through litigation funding and after-the-event insurance, automate volume and class actions and get more clients through working with marketing service providers.
- Robin — Robin AI is a legal tech company based in London, made up of engineers, lawyers, scientists and operations specialists.
- Marshmallow — Digital-first car insurance company with a mission to deliver great prices, service, and coverage.
Naheed Kurji is the President and CEO of Cyclica, a Toronto-based biotechnology company that leverages artificial intelligence and computational biophysics to reshape the drug discovery process. Cyclica provides the pharmaceutical industry with an integrated, holistic, and end-to-end enabling platform that enhances how scientists design, screen,and personalize medicines for patients, and has recently been named by Deep Knowledge Analytics as one of the top 20 AI in Pharma companies globally. Naheed is passionate about how people interact with technology to make more informed and faster decisions, and is dedicated to advancing the responsible application of AI to healthcare problems. At Cyclica, he focuses on strategy and corporate development activities to affect change in the pharmaceutical industry, and strives to foster an environment where his team can solve the biggest challenges in human health through groundbreaking innovation. Naheed is a co-founder of The Alliance for Artificial Intelligence in Healthcare (AAIH), of which Naheed is 1 of 4 appointed Executive Officers. Naheed is an experienced professional specialized in strategic planning, corporate finance and entrepreneurship, having received an MBA from the University of Toronto, Rotman School of Management, and a Certificate from MIT on Artificial Intelligence and the Implication on Business Strategy. He has been featured in the Globe and Mail, CBC, Forbes, Vanity Fair, StartUp Health Magazine, WuXi Insider Perspective, and VentureBeat. Naheed is also a guest lecturer at various universities globally on the topic of entrepreneurship and AI in medicine.
Show more...Investment focus
- Industry: Life Science, Biotechnology
- Stage:Seed
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- CardiaTec Biosciences — CardiaTec is a digital biotechnology venture combining the power of AI and expert talent to redesign cardiovascular drug discovery to deliver the next generation of therapeutics
Jan Hruska
Show more...Investment focus
- Industry: Medical, Health Care, Life Science
- Stage:Seed
- Geography: United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.
Rick Bernstein is the Chief Commercial Officer for MedNet responsible for the development of the commercial infrastructure and strategy for MedNet, a healthcare technology company specializing in eClinical solutions for the global life sciences industry. Rick is currently leading the development of an optimized sales, business development, anddistribution strategy to drive aggressive growth across key market segments, including CROs and pharmaceutical, medical device and biotechnology sponsors.
Show more...Investment focus
- Industry: Biotechnology, AgTech, Farming
- Stage:Seed, Pre-Seed
- Geography: United Kingdom, The Netherlands
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Farmless — A farmless fermentation platform has the potential to create an entirely new food repertoire, producing proteins, carbohydrates, beneficial fats, vitamins, and minerals from the ground up," explained Oner. "We are creating a new interface between food and electricity by domesticating microbes chosen for their food properties and abilityto grow on renewable energy-based feedstocks.
- Phytoform Labs — Phytoform Labs is improving crops to make agriculture more sustainable and nutritious
Principal at Apax Digital.
Show more...Investment focus
- Industry: Rental, Medical, Software
- Stage:Series A, Series D, Series E
- Geography: Israel, United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Guesty — Guesty simplifies the way property managers work.
- MIP Diagnostics — MIP Diagnostics develop and manufacture molecularly imprinted polymers (nanoMIPs) that act as synthetic alternatives to antibodies for IVD and other industries.
John Anthony Knight
Show more...Investment focus
- Industry: Software, Life Science, Biotechnology
- Stage:Seed
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Synthace — The Synthace Experiment Platform lets you design powerful experiments, run them in your lab, & gather automatically structured datasets. No code necessary.
Maximilien Levesque - CEO and co-founder @ AQEMIA
Show more...Investment focus
- Industry: Life Science, Biotechnology
- Stage:Seed
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- CardiaTec Biosciences — CardiaTec is a digital biotechnology venture combining the power of AI and expert talent to redesign cardiovascular drug discovery to deliver the next generation of therapeutics
Sharaf Yamani - Managing Director @ Windlesham Advisors
Show more...Investment focus
- Industry: Biotechnology, Software, Life Science
- Stage:Seed
- Geography: India, United Kingdom
Investor stats
- Total investments: 2
- Round size: Seed $900k–$1.4M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- CyGenica — CyGenica uses a non-viral, non-toxic platform to develop in vitro and in vivo delivery solutions for drugs, gene editing components, and antibiotics.
- Synthace — The Synthace Experiment Platform lets you design powerful experiments, run them in your lab, & gather automatically structured datasets. No code necessary.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Amar Shah is based out of London and is the Founder & Partner of Dhyan VC. Amar previously worked at Firstminute Capital as an Entrepreneur In Residence. Amar Shah attended the University of Cambridge.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Health Care
- Stage:Pre-Seed, Seed, Angel
- Geography: United Kingdom, Poland, Germany
Investor stats
- Total investments: 10
- Round size: Seed $4.8M–$15M; Pre-Seed $642k–$2.8M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- TextCortex — Create the highest quality content 7x faster, using TextCortex AI - the best copywriting tool for all your content. Get started for free, no credit card required.
- PHINXT Robotics — PHINXT Robotics enables warehouses of any size to deploy autonomous robots as needed, with no expertise required.
- Martian Lawyers Club — Home of GUG and Nomic
Irina Haivas is a Principal. Based in London, she works on sourcing and due diligence of global investment opportunities.Irina focuses on businesses that use advanced technologies such as machine intelligence or robotics and automation, to transform large industries. She also focuses on the intersection of science and technology, including nextgeneration biology, as well as on companies in healthcare.Before joining Atomico, Irina was a growth and PE investor at GHO Capital Partners, where she invested, among others, in enterprise software and AI/ML businesses and focused on the intersection of science, healthcare and technology. Before that, Irina was part of the leadership team of Bain & Co. in Europe and the U.S., where she worked directly both with private equity firms on investment diligence, as well as with corporates on Innovation and Product, Go-to-Market, BD and acquisitions, and organisation scale-up. While at Bain she seconded in an operational role at Medtronic, one of the world’s largest medical engineering companies.Irina is a former surgeon, having studied medicine at Freiburg University in Germany and Iasi Medical University in Romania. She was a surgical fellow at Harvard Medical School before completing an MSc (Dist) in International Health Policy at London School of Economics.Irina speaks Romanian, English, advanced German, and conversational French.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Artificial Intelligence
- Stage:Series A, Series B, Seed
- Geography: United Kingdom, Estonia, Germany
Investor stats
- Total investments: 10
- Round size: Series A $11M–$31M; Series B $46M–$56M
- Lead/follow: 80% lead, 20% follow
Portfolio highlights
- Y42 — Y42's Turnkey Data Orchestration Platform gives you a unified space to build, monitor and maintain a robust flow of data to power your business
- Daye — Daye has set out to build a new brand for female health products “designed with women in mind.” The startup’s first product is a newly developed tampon that uses CBD to help tackle period cramps (or dysmenorrhea) as an alternative to traditional painkillers (CBD is the extract derived from the flower of the industrial hemp plant, a legal relativeto marijuana).
- Qatalog — Connect tools, resources and teams in one digital Work Hub. Find information quickly, collaborate effectively. Set up your Work Hub.
Sami Mikati is a Director of Synthace Ltd. Investor and commercial executive with deep experience and network across energy and engineering industries in Europe, the Middle East and Africa.
Show more...Investment focus
- Industry: Biotechnology, Software, Life Science
- Stage:Seed
- Geography: India, United Kingdom
Investor stats
- Total investments: 2
- Round size: Seed $900k–$1.4M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- CyGenica — CyGenica uses a non-viral, non-toxic platform to develop in vitro and in vivo delivery solutions for drugs, gene editing components, and antibiotics.
- Synthace — The Synthace Experiment Platform lets you design powerful experiments, run them in your lab, & gather automatically structured datasets. No code necessary.
Patrick Pichette is based out of London, England, and is the Partner of Inovia Capital and also Board Member of Cohere. Patrick Pichette previously worked at Twitter as a Board of Directors. Patrick Pichette attended the University of Oxford.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Machine Learning
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, Germany, United States
Investor stats
- Total investments: 21
- Round size: Seed $750k–$10M; Series A $10M–$95M; Series B $15M–$95M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- Kaedim — AI-powered 3D asset creation service delivering fast, production-ready 3D assets. Scale 3D pipelines without hiring, accelerate 3D game art production, and reduce 3D asset costs by up to 90%.
- Apheris — Superior drug discovery models through federated data networks
- made of air — Made of Air is a carbon-negative materials company. They take low-value wood waste and transform it into high-value, carbon-negative thermoplastics. These thermoplastics can be formed with all traditional heat-forming methods and used for a wide variety of applications, turning manufactured goods into engineered carbon sinks.
David Lucas
Show more...Investment focus
- Industry: Software, Life Science, Biotechnology
- Stage:Seed
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Synthace — The Synthace Experiment Platform lets you design powerful experiments, run them in your lab, & gather automatically structured datasets. No code necessary.
Life Science Angel investor funding in United Kingdom at a glance
Stats across 53 deals from 58 investors.
Access all 58 angel investors in United Kingdom Life Science startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science Angel Investors in United Kingdom investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 58 angel investors investing in United Kingdom Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!